Likewise, higher expression of the NPAS2 gene in tumor tissue was closely related with immune infiltration and overall survival of glioma patients [102] as well as with immune infiltration and poor prognosis in hepatocellular carcinoma patients [103,104]. This evidence concerns the gene NPAS2 and hepatocellular carcinoma.